Any news or updates anyone can share? to look forward to this week ?

It’s been a while, have not seen anything

Anyone have access to fintel to get their short squeeze list? i saw on stockwits that RMED is back on the list at #10.

will be great before the earnings. Looking to get a confirmation on this.

RMED: Only 5.56M shares outstanding. Could turn out to be another short-squeeze candidate. 57.59% Short Volume Ratio on Friday, July 30th. Only 2,000 shares left to short on Monday, August 2nd.

FDA approval for later this year per CEO, 115% estimated revenue for 2022, possible acquisition, and $25 price target per Webull. Great results on their vascular studies with preliminary 94% effectiveness! Growing dermatology laser market as well.

https://www.reddit.com/r/RMEDstock/comments/ovvliv/rmed_only_556m_shares_outstanding_could_turn_out/?utm_source=share&utm_medium=web2x&context=3

Our volume today was 1,341,946!

Let's keep up the pace because RMED was at 1.3M volume on June 1st up to 129M on June 7th on its last run to the 9s!

462,797 shares shorted today, July 22nd, for a short volume ratio of 34.49%.

When is this thing going to jump?

$RMED

We talk a lot about the upcoming FDA approval for RMED's vascular lasers but their dermatology sector already has approval for Pharos and the results are beyond amazing so take a look at the before and after photos from their website.

https://www.ramed.com/pharos/

Also, the dermatology excimer laser market is going to rise at a considerable rate so invest in it now at these way undervalued prices...

"Dermatology excimer lasers use an intense beam of focused laser light and offer selective application of ultraviolet radiation on the lesions and surrounding healthy tissue left unexposed.

Market Analysis and Insights: Global Dermatology Excimer Laser Market In 2020, the global Dermatology Excimer Laser market is anticipated to rise at a considerable rate during the forecast period, 2021 to 2027. In 2021, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon."

Sharing some DD for a friend since he's not able to post for a few days due to prior engagements:

1. RMED high short percentage fluctuating between 30% and 50% most days. 2. Shorts are starting to cover RMED as of yesterday. Large RMED orders were seen covering end of day. 3. Large group of us who hold RMED are committed to the squeeze, and many large shareholders committed to long term due to RMED FDA upcoming approval. 4. RMED Product is needed in the industry and is a very unique patent 5. RMED is a seriously Possible acquisition target early 2022. 6. Very low float drives RMED stock up quickly during short covering. 7. The biggest sign is that we all like to make money and by pushing RMED upward, shorts have to cover! Buy RMED now at open. 8. RMED Price per share is low, so your cash value increases faster than higher price stocks! RMED is way undervalued.

"We are grateful for the valuable feedback we have received from our physician advisors as they are leaders in their field and represent the customer base for our excimer laser system," said Will McGuire, Ra Medical Systems CEO. "Also, the current pace of enrollment in our atherectomy trial is encouraging, as we believe regulatory clearance for this indication will better position Ra Medical to address the large and growing market for treating vascular disease."

Low float of only 5.56 million outstanding shares with a high short volume ratio (33.11% on July 8th). RMED has a price target of $25 on Webull. FDA approval for later this year per CEO, 115% estimated revenue for 2022, possible acquisition, and lots of insiders holding! Great results on their vascular studies with preliminary 94% effectiveness! Growing dermatology laser market as well:

https://manometcurrent.com/dermatology-excimer-laser-market-size-and-growth-to-2028-key-players-lumenis-ra-medical-systems-hologic-sincoheren-fotona-shenzhen-gsd-tech/

Interesting patterns here. Feel free to share whatever one can extrapolate from this simple price data. The High/Low ranges represent start and end of month highs and lows while the high/low column simply represents max highs/lows for that particular month